Abstract
Mortality data were retrieved from the Swedish death registry for the years 1970-2006. This report presents updated information on mortality from Alzheimers disease (AD) through the year 2006, as well as a statistical model of AD mortality with predictive value. This model was developed based on a mortality risk function acting after a specific time point, either step-wise on the whole population or on an increasing part of it. Data collected in recent years indicate that mortality is increasing continuously amongst the oldest patients, while younger age-groups show more stable mortality rates. After fitting the statistical model to age-standardized mortality data it also gave age-specific rates that fit well with reported data without further adjustments in model parameters. The data and the corresponding model for AD mortality suggest that the ability of the body to protect itself from AD-related neurological damage has in general became increasingly impaired since about 1985. This impairment has mainly affected people 65 years of age and older since 1985; the model predicts that in 2020, the age-standardized mortality in Sweden will be 13/100,000 person-years. The author concludes that the increasing mortality is real and not only a result of increasing use of the death classification code for AD.
Keywords: Alzheimer's disease, mortality, mobile phone, blood-brain barrier
Current Alzheimer Research
Title: Is Increased Mortality from Alzheimers Disease in Sweden a Reflection of Better Diagnostics?
Volume: 6 Issue: 6
Author(s): Orjan Hallberg
Affiliation:
Keywords: Alzheimer's disease, mortality, mobile phone, blood-brain barrier
Abstract: Mortality data were retrieved from the Swedish death registry for the years 1970-2006. This report presents updated information on mortality from Alzheimers disease (AD) through the year 2006, as well as a statistical model of AD mortality with predictive value. This model was developed based on a mortality risk function acting after a specific time point, either step-wise on the whole population or on an increasing part of it. Data collected in recent years indicate that mortality is increasing continuously amongst the oldest patients, while younger age-groups show more stable mortality rates. After fitting the statistical model to age-standardized mortality data it also gave age-specific rates that fit well with reported data without further adjustments in model parameters. The data and the corresponding model for AD mortality suggest that the ability of the body to protect itself from AD-related neurological damage has in general became increasingly impaired since about 1985. This impairment has mainly affected people 65 years of age and older since 1985; the model predicts that in 2020, the age-standardized mortality in Sweden will be 13/100,000 person-years. The author concludes that the increasing mortality is real and not only a result of increasing use of the death classification code for AD.
Export Options
About this article
Cite this article as:
Hallberg Orjan, Is Increased Mortality from Alzheimers Disease in Sweden a Reflection of Better Diagnostics?, Current Alzheimer Research 2009; 6(6) . https://dx.doi.org/10.2174/156720509790147098
DOI https://dx.doi.org/10.2174/156720509790147098 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment)
Current Radiopharmaceuticals Combining Drug-Loaded Nanobubbles and Extracorporeal Shock Waves for Difficult-to-Treat Cancers
Current Drug Delivery Imaging Tumor Metastases with Molecular Probes
Current Pharmaceutical Design Microarray Technology as a Universal Tool for High-Throughput Analysis of Biological Systems
Combinatorial Chemistry & High Throughput Screening Integrins as A New Target for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry The Central Role Played by Peptides in the Immune Response and the Design of Peptide-Based Vaccines Against Infectious Diseases and Cancer
Current Drug Targets Postnatal Repeated Mild Stress and DEγE Treatment Induce a Reduction of S of DBA/2J in Mice
Letters in Drug Design & Discovery Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors
Current Medicinal Chemistry Anti-Carcinogenic Effects of Carnosol-An Updated Review
Current Drug Discovery Technologies Recent Advances Using Supercritical Fluid Techniques for Pulmonary Administration of Macromolecules via Dry Powder Formulations
Drug Delivery Letters Biological Predictors of Aging and Potential of FTIR to Study Age-related Diseases and Aging Metabolic Fingerprint
Current Metabolomics Nitric Oxide: Cancer Target or Anticancer Agent?
Current Cancer Drug Targets The Advancement of Human Serum Albumin-Based Molecular Probes for Molecular Imaging
Current Pharmaceutical Design Law-Medicine Interfacing: Patenting of Human Genes and Mutations
Recent Patents on DNA & Gene Sequences RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy
Current Topics in Medicinal Chemistry Impact of Sex Hormone Metabolism on the Vascular Effects of Menopausal Hormone Therapy in Cardiovascular Disease
Current Drug Metabolism Zinc Tetrafluoroborate Catalyzed Synthesis, Molecular Docking and Cytotoxicity of Pyrrolidinyl Aminophosphonates
Letters in Drug Design & Discovery Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Current Understanding of Dietary Polyphenols and their Role in Health and Disease
Current Nutrition & Food Science Targeted Cancer Therapy; Nanotechnology Approaches for Overcoming Drug Resistance
Current Medicinal Chemistry